5-11

InfoWars – FDA Documents Show Pfizer Secretly Added Heart Attack Drug to Children’s COVID Vaccines

Source: https://banned.video/watch?id=618c7b9111848a41725b16e2

The Food and Drug Administration (FDA) Advisory Committee that voted 17-0 to approve the jabs for children as young as five was notified that the children’s formulation of the drug contains tromethamine (Tris), a chemical that reduces blood acidity and stabilizes people who have suffered a heart attack.

https://theexpose.uk/2021/11/01/pfizer-adds-ingredient-to-vaccine-for-kids-that-treats-heart-attacks/

Vaccines and Related Biological Products Advisory Committee Meeting
October 26, 2021
FDA Briefing Document
EUA amendment request for Pfizer-BioNTech COVID-19 Vaccine for use in children 5 through 11 years of age

PDF: https://www.fda.gov/media/153447/download

Page 14, Chapter 5

Vaccine formulation
To provide a vaccine with an improved stability profile, the Pfizer-BioNTech COVID-19 Vaccine for use in children 5-11 years of age uses tromethamine (Tris) buffer instead of the phosphatebuffered saline (PBS) as used in the previous formulation and excludes sodium chloride and potassium chloride. The packaged vials for the new formulation are stored frozen at -90°C to – 60°C. The frozen vials may be thawed and stored at refrigerator at 2°C to 8°C for up to 10 weeks.

https://www.drugs.com/cdi/tromethamine.html

Uses of Tromethamine:
It is used to treat or prevent acid problems in the blood.

What do I need to tell my doctor BEFORE I take Tromethamine?
For all patients taking tromethamine:

If you have an allergy to tromethamine or any other part of tromethamine.
If you are allergic to tromethamine; any part of tromethamine; or any other drugs, foods, or substances. Tell your doctor about the allergy and what signs you had.
If you are not able to pass urine.

Children:

This medicine is not for newborns who have any of these problems: High blood carbon dioxide levels or too much salicylate in the body.
This is not a list of all drugs or health problems that interact with tromethamine.

What are some things I need to know or do while I take Tromethamine?
For all patients taking tromethamine:

Tell all of your health care providers that you take tromethamine. This includes your doctors, nurses, pharmacists, and dentists.
Have blood work checked as you have been told by the doctor. Talk with the doctor.
Check your blood sugar as you have been told by your doctor.
Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using tromethamine while you are pregnant.
Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.

Children:

Use with care in children. Talk with the doctor.
How is this medicine (Tromethamine) best taken?
Use tromethamine as ordered by your doctor. Read all information given to you. Follow all instructions closely.

It is given as an infusion into a vein over a period of time.

https://www.drugs.com/dosage/tromethamine.html

Tromethamine Dosage
Applies to the following strengths: 3.6 g/100 mL

Usual Pediatric Dose for Metabolic Acidosis
Associated with RDS in Neonates and Infants:
1 mL/kg for each pH unit below 7.4

Dose Adjustments
Dosage should be limited to an amount sufficient to increase blood pH to normal limits (7.35 to 7.45) and to correct acid-base derangements

Estimate the IV dosage of tromethamine injection from the buffer base deficit of the extracellular fluid in mEq/liter determined by means of the Siggaard-Andersen nomogram.

Use the following formula as a general guide:
Tromethamine solution (mL of 0.3 M) required =
Body Weight (kg) X
Base Deficit (mEq/liter) X 1.1

Note: Factor of 1.1 accounts for an approximate reduction of 10% in buffering capacity due to the presence of sufficient acetic acid to lower pH of the 0.3 M solution to approximately 8.

https://www.drugs.com/sfx/tromethamine-side-effects.html

Side effects include:

Adverse effects may include respiratory depression, local irritation, tissue inflammation, injection site infection, febrile response, chemical phlebitis, venospasm, hypervolemia, IV thrombosis, extravasation (with possible necrosis and sloughing of tissues), transient decreases in blood glucose concentrations, hypoglycemia, and hepatocellular necrosis with infusion via low-lying umbilical venous catheters. (See Warnings under Cautions.)


Why has Pfizer changed the formulation of its Covid-19 Vaccine for Children to include an ingredient that stabilises people suffering a Heart Attack?
A document prepared for the FDA Advisory Committee meeting, in which members voted seventeen to zero in favour of giving emergency use authorisation for the administration of the Pfizer Covid-19 injection to children aged 5 to 11, confirms that Pfizer have modified the formulation of their injection for children to include an ingredient that reduces the acidity of blood and is used to stabilise people who have suffered a heart attack.

InfoWars – San Francisco Becomes First City in the WORLD To Mandate COVID Injection For Children 5-11

Source: https://www.infowars.com/posts/san-francisco-becomes-first-city-in-the-world-to-mandate-covid-injection-for-children-5-11/

by Jamie White

Just a day after the Centers for Disease Control and Prevention (CDC) gave emergency use authorization of the COVID-19 injection to children 5 to 11, the San Francisco government has immediately moved to mandate it for all children in the Bay Area.

The San Francisco Department of Public Health (SFDPH) announced during a town hall on Tuesday that vaccine passport requirements already imposed on the city will be expanded to include children 5 to 11 years old.

“A related question which people have asked me, which is, what about the local San Francisco health orders that require vaccination to go into a restaurant or go to a Warriors game, when is that going to apply to children 5 to 11?” Dr. Susan Phililp, SFDPH director of Disease Prevention and Control Branch said.

“We definitely want to wait and make sure that children have an opportunity to get vaccinated, so that will happen no sooner than about 8 weeks after the vaccine is available to kids.”

FDA Approved ‘First Oral Blood Thinning Medication For Children’ Ahead Of Vaccine Rollout For Ages 5-11

by Andrew White | National File

Source: https://www.infowars.com/posts/fda-approved-first-oral-blood-thinning-medication-for-children-ahead-of-vaccine-rollout-for-ages-5-11/

The Food and Drug Administration approved the “first oral blood thinning medication for children” a few months ahead of their COVID-19 vaccine rollout for children ages 5-11.

In late June 2021, the Food and Drug Administration (FDA) approved a drug called Pradaxa; oral pellets to treat children 3 months to less than 12 years of age with venous thromboembolism, a condition that involves blood clots forming in the veins. Pradaxa is the “first FDA-approved blood thinning medication that children can take by mouth,” reads the FDA News Release.

“With today’s approval of Pradaxa, pediatric patients have another therapeutic option to treat and prevent potentially deadly blood clots,” said Ann Farrell, M.D., director of the Division of Non-Malignant Hematology for the FDA Center for Drug Evaluation and Research.

A few months later, the FDA authorized children ages 5-11 to be injected with the Pfizer COVID-19 shot.

FDA Approves First Oral Blood Thinning Medication for Children

Source: https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-blood-thinning-medication-children

For Immediate Release:June 21, 2021

Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly after they have been treated with a blood thinner given by injection for at least five days. The FDA also approved Pradaxa oral pellets to prevent recurrent clots among patients 3 months to less than 12 years old who completed treatment for their first venous thromboembolism.